DE69024843T2 - Rhodanin-Derivate und pharmazeutische Zusammensetzungen - Google Patents

Rhodanin-Derivate und pharmazeutische Zusammensetzungen

Info

Publication number
DE69024843T2
DE69024843T2 DE69024843T DE69024843T DE69024843T2 DE 69024843 T2 DE69024843 T2 DE 69024843T2 DE 69024843 T DE69024843 T DE 69024843T DE 69024843 T DE69024843 T DE 69024843T DE 69024843 T2 DE69024843 T2 DE 69024843T2
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
rhodanine derivatives
rhodanine
derivatives
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69024843T
Other languages
English (en)
Other versions
DE69024843D1 (de
Inventor
Hitoshi Inoue
Hiroki Kato
Noriyoshi Sueda
Yoshiyuki Tahara
Nobuhiro Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2111761A external-priority patent/JPH0372471A/ja
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Application granted granted Critical
Publication of DE69024843D1 publication Critical patent/DE69024843D1/de
Publication of DE69024843T2 publication Critical patent/DE69024843T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69024843T 1989-05-19 1990-05-11 Rhodanin-Derivate und pharmazeutische Zusammensetzungen Expired - Fee Related DE69024843T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12425289 1989-05-19
JP2111761A JPH0372471A (ja) 1989-05-19 1990-05-01 ロダニン誘導体

Publications (2)

Publication Number Publication Date
DE69024843D1 DE69024843D1 (de) 1996-02-29
DE69024843T2 true DE69024843T2 (de) 1996-05-30

Family

ID=26451089

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69024843T Expired - Fee Related DE69024843T2 (de) 1989-05-19 1990-05-11 Rhodanin-Derivate und pharmazeutische Zusammensetzungen

Country Status (4)

Country Link
US (1) US5116855A (de)
EP (1) EP0398179B1 (de)
CA (1) CA2016665C (de)
DE (1) DE69024843T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
US5158966A (en) * 1991-02-22 1992-10-27 The University Of Colorado Foundation, Inc. Method of treating type i diabetes
US5236941A (en) * 1992-06-30 1993-08-17 American Home Products Corporation 5-(2-hydroxy-1-arylethylidene)- and 5-(2-oxo-1-arylethylidene)-2,4-thiazolidinediones and derivatives thereof
EP0915090A1 (de) * 1992-09-10 1999-05-12 Eli Lilly And Company Thiazolidinone Derivate als hypoglykämisches Mittel und für die Behandlung der Alzheimer Krankheit
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
MX9705557A (es) * 1995-01-23 1997-10-31 Lilly Co Eli Metodo y composiciones para el tratamiento de la esclerosis multiple.
AU6331099A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
US9493452B2 (en) 2011-03-24 2016-11-15 Southern Methodist University Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
US8669363B2 (en) 2011-03-24 2014-03-11 Southern Methodist University Quinoxaline compounds and derivatives
WO2013142831A1 (en) 2012-03-23 2013-09-26 Southern Methodist University Methods of making and using thioxothiazolidine and rhodanine derivatives as hiv-1 and jsp-1 inhibitors
CN108658891B (zh) * 2018-07-03 2020-09-29 河南农业大学 2-硫代噻唑烷-4-酮、衍生物及其制备方法
AT521507B1 (de) 2019-03-08 2020-02-15 Ferdinand Leibetseder Futterspender

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5728074A (en) * 1980-07-28 1982-02-15 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation, and inhibitor for aldose reducing enzyme consisting essentially of it
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
JPS60136575A (ja) * 1983-11-29 1985-07-20 Kaken Pharmaceut Co Ltd ロ−ダニン誘導体およびその製造法
ES537999A0 (es) * 1983-11-29 1985-12-01 Kaken Pharma Co Ltd Un procedimiento para preparar un derivado de rodanina
JPS60156387A (ja) * 1984-12-05 1985-08-16 Ono Pharmaceut Co Ltd ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤
US4897406A (en) * 1987-11-13 1990-01-30 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0398179A1 (de) 1990-11-22
EP0398179B1 (de) 1996-01-17
US5116855A (en) 1992-05-26
DE69024843D1 (de) 1996-02-29
CA2016665A1 (en) 1990-11-19
CA2016665C (en) 2000-10-10

Similar Documents

Publication Publication Date Title
DE10199066I1 (de) Pharmazeutische Zusammensetzung
DE69124721D1 (de) Carbostyrilderivate und diese enthaltende pharmazeutische Zusammensetzungen
FR2636532B1 (fr) Compositions pharmaceutiques
DK481989A (da) Farmaceutiske formuleringer
DE3486441T2 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
DE69014351T2 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DK489189A (da) Farmaceutisk praeparat
IT1239542B (it) Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
DE69024843T2 (de) Rhodanin-Derivate und pharmazeutische Zusammensetzungen
NZ236483A (en) Glycerol derivatives and pharmaceutical compositions thereof
DE69415570D1 (de) Esculetin Derivate und pharmazeutische Zusammenstellung
DK603988D0 (da) Farmaceutisk praeparat
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
NZ232701A (en) Substituted benzoxazolinone derivatives and pharmaceutical compositions
DE3782378T2 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
DK336489A (da) Farmaceutisk praeparat
KR960009424B1 (en) Rhodanine derivatives and pharmaceutical compositions
DK0511991T3 (da) Farmaceutisk formulering
NZ233940A (en) Cyclised n-oxo-tetrahydro-beta-carboline derivatives and pharmaceutical compositions thereof
ATA321188A (de) Pharmazeutische zubereitung
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NISSHIN SEIFUN GROUP INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee